May 07, 2024 | The Legal Intelligencer
Unworthy Medical Marijuana Dispensaries and the Importance of Weeding Them OutThe goal of the MMA is to "provide a program of access to medical marijuana which balances the need of patients to have access to the latest treatments with the need to promote patient safety" and to "provide a safe and effective method of delivery of medical marijuana to patients."
By Joshua Horn and Brooke Hurlbrink
6 minute read
May 18, 2023 | The Legal Intelligencer
A Name Is Just a Name, Unless It Is a Strain NameThis article outlines what the department is doing, why its conduct may raise concerns given state rulemaking obligations, and how that could harm Pennsylvanians in the state's medical marijuana program.
By Joshua Horn and Robert H. Eisentrout
8 minute read
July 11, 2022 | New York Law Journal
Selling Hemp Futures: The Sky May Be the LimitCBD and hemp businesses may consider minimizing the need for CFTC and NFA registration, and onerous registration and disclosure requirements if structured correctly.
By Ernest Edward Badway and Joshua Horn
11 minute read
May 13, 2022 | The Legal Intelligencer
US Investments in Foreign Cannabis: Unspoken Safe Harbor or Federal Tripwire?The nascent cannabis industry opens up just as many risks as it does opportunities. Anyone considering investments touching on that industry would be wise to stop and investigate the opportunity carefully before signing on the dotted line.
By Joshua Horn and Saverio S. Romeo
6 minute read
December 31, 2019 | The Legal Intelligencer
The Growth of Hemp in the US—an Ever-Changing Regulatory EnvironmentThe emergence of the hemp crop in U.S. markets has been slowed by a confusing and inconsistent regulatory environment at both the state and federal levels.
By Joshua Horn and Jesse Harris
6 minute read
June 25, 2019 | The Legal Intelligencer
FDA Hearing on Cannabis Products—CBD Takes Center StageWhile the president and Congress gave hemp the go-ahead, it is now on the regulators to take the next step. The FDA has authority to regulate cannabis-derived compounds, including CBD, under the Federal Food, Drug, and Cosmetic Act. So far, though, the FDA has not done much regulating in regards to CBD.
By Joshua Horn and Ellis W. Martin
7 minute read
June 21, 2019 | New Jersey Law Journal
The 2018 Farm Bill, Hemp and Interstate CommerceAmong other things, the 2018 Farm Bill removed hemp from the Controlled Substances Act, unlocking a new industry that is poised to make serious waves throughout the agricultural sector and beyond.
By Joshua Horn and Jesse M. Harris
8 minute read
May 23, 2018 | The Legal Intelligencer
Cannabis and Banks: What Qualifies as Illegal Activity?Many legal issues arise out of financing cannabis activities, not the least of which is whether a target property for a cannabis venture is mortgaged by a bank. The standard institutional mortgage contains language that allows the mortgagee to “call” the loan if the property is being used to conduct “illegal activity.”
By Joshua Horn and Jesse M. Harris
6 minute read
August 01, 2006 | The Legal Intelligencer
The Unfulfilled Qwest For a 'Selective Waiver'Faced with the prospect of ever-increasing governmental/regulatory investigations, companies are frequently confronted with the opportunity to disclose information to federal agencies for various reasons, including the possibility of more favorable treatment. A dilemma arises when that production requires the disclosure of information protected by the attorney-client privilege or work-product doctrine.
By Joshua Horn and Beth L. Domenick
7 minute read
August 08, 2008 | Law.com
A Creative Screening of Electronically Stored Information May Determine the VictorElectronically stored information (?ESI?) is not an issue that can be put on the back burner and dealt with in a piecemeal fashion after litigation ensues. The painful results of such an approach were the subject of Magistrate Judge Grimm?s recent decision in Victor Stanley, Inc. v. Creative Pipe, Inc., et al.
By Joshua Horn and Beth L. Domenick
11 minute read
Trending Stories